STOCK TITAN

Astria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Astria Therapeutics, Inc. (ATXS) CEO, Dr. Jill C. Milne, to participate in a fireside chat at the Oppenheimer 34th Annual Healthcare Life Sciences Conference. The webcast will be available on February 13th at 9:20am ET, with a replay accessible for 30 days.
Positive
  • None.
Negative
  • None.

BOSTON--(BUSINESS WIRE)-- Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will participate in a fireside chat at the upcoming virtual Oppenheimer 34th Annual Healthcare Life Sciences Conference on Tuesday, February 13th at 9:20am ET.

A webcast of the presentation can be accessed at the following link: https://wsw.com/webcast/oppenheimer33/atxs/2815552. An archived replay of the presentation will be available in the investors section of www.astriatx.com for 30 days following the event.

About Astria Therapeutics:

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema. Our second program, STAR-0310, is a monoclonal antibody OX40 antagonist in preclinical development for the treatment of atopic dermatitis. Learn more about our company on our website, www.astriatx.com, or follow us on X and Instagram @AstriaTx and on Facebook and LinkedIn.

Astria Contact:

Investor Relations and Media:

Elizabeth Higgins

investors@astriatx.com

Source: Astria Therapeutics, Inc.

FAQ

When is the Oppenheimer 34th Annual Healthcare Life Sciences Conference?

The conference will take place on February 13th.

What time will Dr. Jill C. Milne's fireside chat be held?

The chat will be held at 9:20am ET.

Where can the webcast of the presentation be accessed?

The webcast can be accessed at the following link: https://wsw.com/webcast/oppenheimer33/atxs/2815552.

How long will the replay of the presentation be available?

The replay will be available for 30 days in the investors section of www.astriatx.com.

Astria Therapeutics, Inc.

NASDAQ:ATXS

ATXS Rankings

ATXS Latest News

ATXS Stock Data

535.00M
49.64M
0.47%
101.64%
5.14%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BOSTON